Paul Ruff to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Paul Ruff has written about Dose-Response Relationship, Drug.
Connection Strength
0,034
-
Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. J Clin Oncol. 2007 Jul 20; 25(21):3069-75.
Score: 0,018
-
A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy. Int J Gynecol Cancer. 2006 Jul-Aug; 16(4):1614-9.
Score: 0,016